Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Pan American Silver Corp. Common Stock (PAAS) Price & Performance

Edgewise Therapeutics Inc. Common StockTrade
Pan American Silver Corp. Common StockTrade

Price performance (Past 24H)

Key statistics

Edgewise Therapeutics Inc. Common Stock vs Pan American Silver Corp. Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.14 (market cap $4.02B), while Pan American Silver Corp. Common Stock trades at $43.16 (market cap $17.55B). The key difference: Pan American Silver Corp. Common Stock is far larger — about 4.4× Edgewise Therapeutics Inc. Common Stock's market cap, and Pan American Silver Corp. Common Stock pays a 1.74% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Pan American Silver Corp. Common Stock for 2 Days on average.

EWTXPAAS
Market Cap
$4.02B$17.55B
Volume
1,446,1286,423,301
Sector
HealthBasic Materials
52-Week High
$48.35$68.70
52-Week Low
$14.89$33.20
Typical Hold Time
0 Days2 Days
Enterprise Value
$3.56B$16.69B
Dividend Yield
—1.74%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Edgewise Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Pan American Silver Corp. Common Stock

Pan American Silver (PAAS) trades at $44.53, down 2.58% on the day, with a bearish technical signal from moving averages. The company reported strong 2025 results with $978M net income and a 32.03% net margin, and analysts project 2026 revenue growth to $4.3B. Recent news highlights growth from the Timmins and La Colorada projects and a director retirement effective October 31, 2026.

The outlook is positive with a consensus price target of $62.50, implying 40% upside, supported by solid cash flow and reserve growth. Risks include silver price volatility and potential cost pressures. Analyst sentiment is bullish with 52% buy ratings, but technical indicators suggest near-term caution.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EWTX
100% Buy0% Sell
Avg holding period · 0 Days
PAAS
100% Buy0% Sell
Avg holding period · 2 Days

About Edgewise Therapeutics Inc. Common Stock

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.

Read more on EWTX →

About Pan American Silver Corp. Common Stock

Pan American Silver is a mining company focused on silver and gold production in the Americas. It also explores and develops precious metals properties.

Read more on PAAS →